Natarajan Sethuraman insider trades
Open-market stock purchases and sales by Natarajan Sethuraman, President, Research & Develop. at Entrada Therapeutics, Inc, from SEC Form 4 filings since Oct 28, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc | Sold (not open market) | $14.9K |
| May 4, 2026 | TRDA Entrada Therapeutics, Inc | Sold | $399K |
| Mar 3, 2026 | TRDA Entrada Therapeutics, Inc | Sold (not open market) | $89.1K |
| Mar 2, 2026 | TRDA Entrada Therapeutics, Inc | Sold (not open market) | $45.4K |
| Mar 1, 2026 | TRDA Entrada Therapeutics, Inc | Bought (not open market) | — |
| Mar 1, 2026 | TRDA Entrada Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TRDA Entrada Therapeutics, Inc: 21 sales, last Sep 2, 2026
Get free alerts when Natarajan Sethuraman files a new trade →